HCW Biologics Inc. (HCWB)
USD 0.41
(25.0%)
USD 0.41
(25.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -22.51 Million | -10.38 Million | -10.97 Million | -10.43 Million | -6.76 Million |
| Net Income | -24.99 Million | -14.9 Million | -12.86 Million | -5.8 Million | -7.29 Million |
| Depreciation & Amortization | 1.13 Million | 717.85 Thousand | 543.59 Thousand | 595.91 Thousand | 421.81 Thousand |
| Deferred income taxes | -501.29 Thousand | - | -501.47 Thousand | -4.31 Million | -79 Thousand |
| Stock-based compensation | 1 Million | 1.12 Million | 360.97 Thousand | 21.87 Thousand | 1763.00 |
| Change in working capital | -4.64 Million | 2.48 Million | 1.45 Million | -5.24 Million | 104.17 Thousand |
| Other non-cash items | 5.48 Million | 188.45 Thousand | 28.25 Thousand | 4.31 Million | 79 Thousand |
| Investing Cash Flow | 3.79 Million | 14.7 Million | -35.01 Million | -186.68 Thousand | -1.46 Million |
| Investments in PPE | -6.2 Million | -10.27 Million | -47.26 Thousand | -186.68 Thousand | -1.46 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | -34.97 Million | - | - |
| Sales/Maturities of investments | 10 Million | 24.98 Million | - | - | - |
| Other Investing Activities | 10 Million | 24.98 Million | -34.97 Million | - | 164.00 |
| Financing Cash Flow | -14.53 Thousand | 6.27 Million | 49.26 Million | 11.71 Million | 13.44 Million |
| Debt repayment | -38.27 Thousand | -6.44 Million | - | -563.59 Thousand | - |
| Dividends payments | - | - | -2.82 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 23.73 Thousand | 15.77 Thousand | 56.02 Million | 9898.00 | 60.28 Thousand |
| Other Financing Activities | -38.27 Thousand | 12.7 Million | -3.93 Million | 12.27 Million | 13.38 Million |
| Accounts receivables | -1.11 Million | -284.69 Thousand | 2.36 Million | -2.5 Million | - |
| Accounts payables | 1.61 Million | 418.2 Thousand | 1.88 Million | -628.64 Thousand | 766.39 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -5.14 Million | 2.35 Million | -2.79 Million | -2.11 Million | -662.22 Thousand |
| Cash at beginning of period | 22.32 Million | 11.73 Million | 8.45 Million | 7.35 Million | 2.13 Million |
| Cash at end of period | 3.59 Million | 22.32 Million | 11.73 Million | 8.45 Million | 7.35 Million |
| Capital Expenditure | -6.2 Million | -10.27 Million | -47.26 Thousand | -186.68 Thousand | -1.46 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -18.73 Million | 10.59 Million | 3.27 Million | 1.1 Million | 5.22 Million |
| Free Cash Flow | -28.71 Million | -20.66 Million | -11.02 Million | -10.61 Million | -8.22 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.28 Million | -7.46 Million | -10.68 Million | -24.99 Million | -4.93 Million | -4.3 Million |
| Depreciation & Amortization | 129.93 Thousand | 243.5 Thousand | 274.55 Thousand | 1.13 Million | 277.45 Thousand | 284.33 Thousand |
| Deferred income taxes | - | - | -409.49 Thousand | -501.29 Thousand | -40.63 Thousand | -110.94 Thousand |
| Stock-based compensation | 239.82 Thousand | 244.68 Thousand | 261.27 Thousand | 1 Million | 219.84 Thousand | 263.42 Thousand |
| Change in working capital | 10.04 Million | 3.37 Million | 1 Million | -4.64 Million | -1.1 Million | -5.52 Million |
| Other non-cash items | -9.14 Million | -2.39 Million | 5.65 Million | 5.48 Million | -627.00 | -627.00 |
| Investing Cash Flow | 18.56 Thousand | -129.7 Thousand | -3.71 Million | 3.79 Million | 9.36 Million | -1.55 Million |
| Investments in PPE | 18.56 Thousand | -129.7 Thousand | -3.71 Million | -6.2 Million | -630.05 Thousand | -1.55 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 10 Million | 10 Million | - |
| Other Investing Activities | - | - | - | 10 Million | 10 Million | - |
| Financing Cash Flow | 1.92 Million | 4.22 Million | -15.25 Thousand | -14.53 Thousand | -8897.00 | 7712.00 |
| Debt repayment | -1.92 Million | -1.72 Million | -8981.00 | -38.27 Thousand | -8981.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 2.5 Million | 14.04 Thousand | 23.73 Thousand | 84.00 | 7712.00 |
| Other Financing Activities | - | 1.72 Million | 14.04 Thousand | -38.27 Thousand | -8897.00 | 7712.00 |
| Accounts receivables | 248.91 Thousand | 631.87 Thousand | -825.67 Thousand | -1.11 Million | -2867.00 | -454.48 Thousand |
| Accounts payables | 9.39 Million | 2.49 Million | 1.22 Million | 1.61 Million | -820.11 Thousand | 494.24 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 401.16 Thousand | 246.09 Thousand | 599.66 Thousand | -5.14 Million | -283.68 Thousand | -5.56 Million |
| Cash at beginning of period | 4.08 Million | 3.59 Million | 11.22 Million | 22.32 Million | 7.44 Million | 18.38 Million |
| Cash at end of period | 1.16 Million | 4.08 Million | 3.59 Million | 3.59 Million | 11.22 Million | 7.44 Million |
| Capital Expenditure | 18.56 Thousand | -129.7 Thousand | -3.71 Million | -6.2 Million | -630.05 Thousand | -1.55 Million |
| Effect of forex changes on cash | - | - | -11 Million | - | - | 11 Million |
| Net cash flow / Change in cash | -2.92 Million | 488.97 Thousand | -7.62 Million | -18.73 Million | 3.77 Million | -10.94 Million |
| Free Cash Flow | -4.84 Million | -3.73 Million | -7.61 Million | -28.71 Million | -6.21 Million | -10.94 Million |
LAL
DAL
2540
0340
CMD
ING